APAnna M. Planas

Anna M. Planas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anna M. Planas has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Roser Gorina

    Department of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Consejo Superior de Investigaciones Científicas (CSIC), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

    6 shared publications
  • Valérie Petegnief

    Department of Neuroscience and Experimental Therapeutics, Institute for Biomedical Research of Barcelona (IIBB), Spanish Research Council (CSIC), 08036 Barcelona, Spain

    5 shared publications
  • Ángel Chamorro

    Stroke Unit, Institut Clínic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic, IDIBAPS, Barcelona, Spain

    5 shared publications
  • Carles Justicia

    Institut d’Investigacions Biomèdiques de Barcelona (IIBB), Consejo Superior de Investigaciones Científicas (CSIC)

    4 shared publications
  • Abraham Martín

    Achucarro Basque Center for Neuroscience, Leioa, Spain

    2 shared publications
  • Angel Messeguer

    Department of Chemical and Biomolecular Nanotechnology, IQAC-CSIC, E-08034 barcelona, Spain

    2 shared publications

Latest Publications

  • Open Access

    Neutrophil recruitment to the brain in mouse and human ischemic stroke

    by Isabel Perez-De-Puig, Francesc Miró-Mur, Maura Ferrer-Ferrer, Ellen Gelpi, Jordi Pedragosa, Carles Justicia, Xabier Urra, Angel Chamorro, Anna M. Planas

    Neutrophils are rapidly recruited in response to local tissue infection or inflammation. Stroke triggers a strong inflammatory reaction but the relevance of neutrophils in the ischemic brain is not fully understood, particularly in the absence of reperfusion. We investigated brain neutrophil recruitment in two murine models of permanent ischemia induced by either cauterization of the distal portion of the middle cerebral artery (c-MCAo) or intraluminal MCA occlusion (il-MCAo), and three fatal cases of human ischemic stroke. Flow cytometry analyses revealed progressive neutrophil recruitment after c-MCAo, lesser neutrophil recruitment following il-MCAo, and absence of neutrophils after sham operation. Confocal microscopy identified neutrophils in the leptomeninges from 6 h after the occlusion, in the cortical basal lamina and cortical Virchow–Robin spaces from 15 h, and also in the cortical brain parenchyma at 24 h. Neutrophils showed signs of activation including histone-3 citrullination, chromatin decondensation, and extracellular projection of DNA and histones suggestive of extracellular trap formation. Perivascular neutrophils were identified within the entire cortical infarction following c-MCAo. After il-MCAo, neutrophils prevailed in the margins but not the center of the cortical infarct, and were intraluminal and less abundant in the striatum. The lack of collaterals to the striatum and a collapsed pial anastomotic network due to brain edema in large hemispheric infarctions could impair neutrophil trafficking in this model. Neutrophil extravasation at the leptomeninges was also detected in the human tissue. We concluded that neutrophils extravasate from the leptomeningeal vessels and can eventually reach the brain in experimental animal models and humans with prolonged arterial occlusion.


  • Advances in Translational Medicine 2010

    by Anna M. Planas, Richard J. Traystman

    A.M.P. receives funding from the Spanish Ministry of Science and Innovation (SAF2008-04515-C01) and by the European Community (FP7/2007-2013; grant agreement number 201024). R.J.T. acknowledges funding from NIH/NINDS R01 NS046072.Peer Reviewe


  • Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88‐dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways

    by Roser Gorina, Miriam Font‐Nieves, Leonardo Márquez‐Kisinousky, Tomàs Santalucia, Anna M. Planas

    There is increasing evidence that astrocytes play important roles in immune regulation in the brain. Astrocytes express toll‐like receptors (TLR) and build up responses to innate immune triggers by releasing proinflammatory molecules. We investigate signaling pathways and released molecules after astrocyte TLR4 activation. Purified rodent brain astrocyte cultures were treated with the TLR4 activator bacterial lipopolysaccharide (LPS). Tools used to interfere with this system include small interference RNA, inhibitory drugs, and MyD88 or Stat1 deficient mice. LPS induced early activation of the transcription factor NFκB, through the MyD88 adaptor, and expression of TNF‐α, VCAM‐1, IL‐15, and IL‐27. LPS also induced delayed Jak1/Stat1 activation, which was MyD88‐independent but was not mediated by IFN‐β. Jak1/Stat1 activation induced the expression of negative cytokine regulator SOCS‐1 and CXCL10 chemokine (IP‐10). Mitogen‐activated protein kinases (MAPK) were also involved in TLR4 signaling in a MyD88‐independent fashion. p38 exerted a strong influence on LPS‐induced gene expression by regulating the phosphorylation of Stat1 and the transcriptional activity of NFκB, while JNK regulated the Jak1/Stat1 pathway, and ERK1/2 controlled the expression of Egr‐1 and influenced MyD88‐dependent MMP‐9 expression. Interplay between these signals was evidenced by the increased induction of MMP‐9 in Stat1‐deficient cells challenged with LPS, suggesting that Stat1 negatively regulates the expression of MMP‐9 induced by LPS. Therefore, astrocytes are responsive to TLR4 activation by inducing a complex set of cell‐dependent molecular reactions mediated by NFκB, MAPK and Jak1/Stat1 signaling pathways. Here we identified cross‐talking signals generating a proinflammatory environment that will modulate the response of surrounding cells.


  • Open Access

    Antioxidant CR-6 Protects against Reperfusion Injury after a Transient Episode of Focal Brain Ischemia in Rats

    by Fernando J Pérez-Asensio, Xavier de la Rosa, Francesc Jiménez-Altayó, Roser Gorina, Emili Martínez, Àngel Messeguer, Elisabet Vila, Àngel Chamorro, Anna M Planas

    Oxidative and nitrosative stress are targets for intervention after ischemia/reperfusion. The aim of this study was to explore the effect of CR-6, a vitamin-E analogue that is antioxidant and scavenger of nitrogen-reactive species. Sprague–Dawley rats had the middle cerebral artery (MCA) occluded either for 90 mins or permanently. Cortical perfusion was continuously monitored by laser–Doppler flowmetry. CR-6 (100 mg/kg) was administered orally either at 2 and 8 h after MCA occlusion, or at 2 h only. Infarct volume, neurological deficit, and signs of reperfusion injury were evaluated. CR-6 was detected in plasma and brain by HPLC. CR-6 reduced glutathione consumption in the ischemic brain and superoxide generation in the isolated MCA. CR-6 decreased infarct volume and attenuated the neurological deficit at 1 and 7 days after ischemia/reperfusion, but not after permanent ischemia. Immediately after reperfusion, cortical blood flow values returned to their baseline (±20%) in several animals, whereas others showed hyper-perfusion (>20% of baseline). Reactive hyperemia was associated with adverse events such as increased cortical BBB leakage, edema, protein nitrotyrosination, COX-2 expression, and neutrophil accumulation; and with a poorer outcome, and CR-6 attenuated these effects. In conclusion, oral CR-6 administration after transient ischemia protects the brain from reperfusion injury.


  • Regulatory T cells protect the brain after stroke

    by Anna M Planas, Angel Chamorro


  • Astrocytes are very sensitive to develop innate immune responses to lipid‐carried short interfering RNA

    by Roser Gorina, Tomàs Santalucia, Valérie Petegnief, Aroa Ejarque‐Ortiz, Josep Saura, Anna M. Planas

    Short interfering RNA (siRNA) inhibits the synthesis of specific proteins through RNA interference (RNAi). However, siRNA can induce innate immune responses that are mediated by toll‐like receptors (TLRs) in cells of the immune system. Here, we sought to evaluate whether siRNA can induce such responses in glial cells. We examined the effects of various siRNA sequences prepared with lipids (oligofectamine). Lipid‐siRNA induced variable degrees of silencing‐independent nonspecific effects, e.g. increased Stat1 and Cox‐2 expression and release of IL‐6 and IP‐10 in primary astroglia. This was prevented through chemical modification of siRNA by nucleoside 2′‐O‐methylation, without impairing specific gene silencing. Lipid‐siRNA also induced nonspecific responses in purified astroglia, but not in microglia, or 3T3 cells. The highest TLR7 and TLR3 mRNA expression was found in microglia and purified astroglia, respectively. Accordingly, the TLR3 agonist poly(I:C) (PIC) induced higher release of IFN‐β in primary and purified astroglia than in microglia. As siRNA, PIC induced IP‐10, Stat1, VCAM‐1, and Cox‐2 and increased TLR3 mRNA expression. The effects of lipid‐siRNA in purified astrocytes were attenuated after silencing TLR3 or TLR7 expression, and by the PKR inhibitor 2‐aminopurine. Furthermore, lipid‐siRNA induced the expression of RIG‐I. In contrast, siRNA devoid of lipids did not enter the astrocytes, did not silence gene expression, and did not induce Stat1 or Cox‐2. The results show that, in astroglia, lipid‐siRNA induces innate immune responses that are mediated, at least in part, by intracellular mechanism dependent on TLR7, TLR3, and helicases.


  • Imaging Brain Inflammation with [11C]PK11195 by PET and Induction of the Peripheral-Type Benzodiazepine Receptor after Transient Focal Ischemia in Rats

    by Santiago Rojas, Abraham Martín, Maria J Arranz, Deborah Pareto, Jesús Purroy, Esther Verdaguer, Jordi Llop, Vanessa Gómez, Joan D Gispert, Olga Milián, et al.

    [11C]PK11195 is used in positron emission tomography (PET) studies for imaging brain inflammation in vivo as it binds to the peripheral-type benzodiazepine receptor (PBR) expressed by reactive glia and macrophages. However, features of the cellular reaction required to induce a positive [11C]PK11195 signal are not well characterized. We performed [11C]PK11195 PET and autoradiography in rats after transient focal cerebral ischemia. We determined [3H]PK11195 binding and PBR expression in brain tissue and examined the lesion with several markers. [11C]PK11195 standard uptake value increased at day 4 and grew further at day 7 within the ischemic core. Accordingly, ex vivo [3H]PK11195 binding increased at day 4, and increases further at day 7. The PET signal also augmented in peripheral regions, but to a lesser extent than in the core. Binding in the region surrounding infarction was supported by [11C]PK11195 autoradiography at day 7 showing that the radioactive signal extended beyond the infarcted core. Enhanced binding was preceded by increases in PBR mRNA expression in the ipsilateral hemisphere, and a 18-kDa band corresponding to PBR protein was detected. Peripheral-type benzodiazepine receptor immunohistochemistry showed subsets of ameboid microglia/macrophages within the infarcted core showing a distinctive strong PBR expression from day 4. These cells were often located surrounding microhemorrhages. Reactive astrocytes forming a rim surrounding infarction at day 7 also showed some PBR immunostaining. These results show cellular heterogeneity in the level of PBR expression, supporting that PBR is not a simple marker of inflammation, and that the extent of [11C]PK11195 binding depends on intrinsic features of the inflammatory cells.


  • Exposure of glia to pro‐oxidant agents revealed selective Stat1 activation by H2O2 and Jak2‐independent antioxidant features of the Jak2 inhibitor AG490

    by Roser Gorina, Coral Sanfeliu, Aida Galitó, Àngel Messeguer, Anna M. Planas

    The JAK/STAT pathway is activated in response to cytokines and growth factors. In addition, oxidative stress can activate this pathway, but the causative pro‐oxidant forms are not well identified. We exposed cultures of rat glia to H2O2, FeSO4, nitroprussiate, or paraquat. We assessed oxidative stress by measuring reactive oxygen species (ROS) and oxidated proteins, we determined phosphorylated Stat1 (pStat1), and we evaluated the effect of antioxidants (trolox, propyl gallate, and N‐acetylcysteine) and of Jak2 (Janus tyrosine kinases) inhibitors (AG490 and Jak2‐Inhibitor‐II). Pro‐oxidant agents induced ROS and protein oxidation, excluding nitroprussiate that induced protein nitrosylation. H2O2, and to a lesser extent FeSO4, increased the level of pStat1, whereas nitroprussiate and paraquat did not. Trolox and propyl gallate strongly prevented ROS formation but they did not abolish H2O2‐induced pStat1. In contrast, NAC did not reduce the level of ROS but it prevented the increase of pStat1 induced by H2O2, evidencing a differential effect on ROS formation and on Stat1 phosphorylation. H2O2 induced pStat1 in mixed glia cultures and, to a lesser extent, in purified astroglia, but not in microglia. Jak2 inhibitors reduced H2O2‐induced pStat1, suggesting the involvement of this kinase in the increased phosphorylation of Stat1 by peroxide. Unexpectedly, AG490, but not Jak2‐Inhibitor‐II, reduced ROS formation, and it abrogated lipid peroxidation in microsomal preparations. Furthermore, AG490 reduced ROS in glial cells that were transfected with siRNA to silence Jak2 expression. These findings reveal previously unrecognized Jak2‐independent antioxidant properties of AG490, and show that Jak2‐dependent Stat1 activation by peroxide is dissociated from ROS generation.


  • Signalling pathways mediating inflammatory responses in brain ischaemia

    by A.M. Planas, R. Gorina, Á. Chamorro

    Stroke causes neuronal necrosis and generates inflammation. Pro-inflammatory molecules intervene in this process by triggering glial cell activation and leucocyte infiltration to the injured tissue. Cytokines are major mediators of the inflammatory response. Pro-inflammatory and anti-inflammatory cytokines are released in the ischaemic brain. Anti-inflammatory cytokines, such as interleukin-10, promote cell survival, whereas pro-inflammatory cytokines, such as TNFα (tumour necrosis factor α), can induce cell death. However, deleterious effects of certain cytokines can turn to beneficial actions, depending on particular features such as the concentration, time point and the very intricate network of intracellular signals that become activated and interact. A key player in the intracellular response to cytokines is the JAK (Janus kinase)/STAT (signal transducer and activator of transcription) pathway that induces alterations in the pattern of gene transcription. These changes are associated either with cell death or survival depending, among other things, on the specific proteins involved. STAT1 activation is related to cell death, whereas STAT3 activation is often associated with survival. Yet, it is clear that STAT activation must be tightly controlled, and for this reason the function of JAK/STAT modulators, such as SOCS (suppressors of cytokine signalling) and PIAS (protein inhibitor of activated STAT), and phosphatases is most relevant. Besides local effects in the ischaemic brain, cytokines are released to the circulation and affect the immune system. Unbalanced pro-inflammatory and anti-inflammatory plasma cytokine concentrations favouring an ‘anti-inflammatory’ state can decrease the immune response. Robust evidence now supports that stroke can induce an immunodepression syndrome, increasing the risk of infection. The contribution of individual cytokines and their intracellular signalling pathways to this response needs to be further investigated.


  • Anti-VCAM-1 Antibodies did not Protect against Ischemic Damage Either in Rats Or in Mice

    by Carles Justicia, Abraham Martín, Santiago Rojas, Meritxell Gironella, Álvaro Cervera, Julían Panés, Ángel Chamorro, Anna M Planas

    Cerebral ischemia triggers an inflammatory process involving the infiltration of leukocytes to the parenchyma. Circulating leukocytes adhere to the vascular wall through adhesion molecules. Here we quantified the in vivo expression of vascular cell adhesion molecule-1 (VCAM-1) in the brain, heart and lungs from 6 to 48 h after transient middle cerebral artery (MCA) occlusion in rats, by intravenous injection of a tracer radiolabeled anti-VCAM-1 antibody. The vascular localization of VCAM-1 was verified by immunohistochemistry after in vivo injection of the antibody. Vascular cell adhesion molecule-1 was strongly induced (4-fold at 24 h) in the microvasculature of the ischemic area, and, to a lesser extent, in the contralateral hemisphere and in a remote organ, the heart, but not in the lungs, indicating that the inflammatory process propagates beyond the injured brain. We injected intravenously either blocking doses of anti-VCAM-1 antibodies or control antibodies after MCA occlusion in rats and mice. We evaluated the neurological score in rats, and infarct volume at 2 days in rats and at 4 days in mice. Anti-VCAM-1 did not protect against ischemic damage either in rats or in mice. Vascular cell adhesion molecule-1 blockade significantly decreased the number of ED1 (labeling monocytes/macrophages/reactive microglia)-positive cells in the ischemic rat brain. However, it did not reduce the numbers of infiltrating neutrophils and lymphocytes, and total leukocytes (CD45 positive), which showed a trend to increase. The results show vascular upregulation of VCAM-1 after transient focal ischemia, but no benefits of blocking VCAM-1, suggesting that this is not a therapeutical strategy for stroke treatment.